Perritt Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-4,342
| Closed | -$1.01M | – | 81 |
|
|
2025
Q3 | $1.01M | Buy |
4,342
+37
| +0.9% | +$7.54K | 0.48% | 38 |
|
|
2025
Q2 | $799K | Sell |
4,305
-70
| -2% | -$13K | 0.41% | 43 |
|
|
2025
Q1 | $917K | Sell |
4,375
-595
| -12% | -$116K | 0.51% | 33 |
|
|
2024
Q4 | $883K | Sell |
4,970
-36
| -0.7% | -$6.62K | 0.46% | 36 |
|
|
2024
Q3 | $989K | Sell |
5,006
-66
| -1% | -$12.3K | 0.51% | 36 |
|
|
2024
Q2 | $870K | Sell |
5,072
-90
| -2% | -$14.9K | 0.48% | 42 |
|
|
2024
Q1 | $940K | Buy |
5,162
+7
| +0.1% | +$1.21K | 0.51% | 39 |
|
|
2023
Q4 | $799K | Sell |
5,155
-925
| -15% | -$135K | 0.45% | 47 |
|
|
2023
Q3 | $906K | Hold |
6,080
| – | – | 0.52% | 44 |
|
|
2023
Q2 | $819K | Sell |
6,080
-517
| -8% | -$75.8K | 0.45% | 50 |
|
|
2023
Q1 | $1.05M | Sell |
6,597
-291
| -4% | -$44.5K | 0.59% | 37 |
|
|
2022
Q4 | $1.11M | Sell |
6,888
-33
| -0.5% | -$5.06K | 0.63% | 32 |
|
|
2022
Q3 | $929K | Sell |
6,921
-54
| -0.8% | -$7.75K | 0.59% | 38 |
|
|
2022
Q2 | $1.07M | Sell |
6,975
-150
| -2% | -$22.9K | 0.65% | 25 |
|
|
2022
Q1 | $1.16M | Sell |
7,125
-778
| -10% | -$113K | 0.62% | 30 |
|
|
2021
Q4 | $1.07M | Buy |
7,903
+55
| +0.7% | +$6.5K | 0.55% | 38 |
|
|
2021
Q3 | $847K | Buy |
7,848
+460
| +6% | +$52.6K | 0.46% | 53 |
|
|
2021
Q2 | $832K | Buy |
7,388
+1,830
| +33% | +$206K | 0.43% | 56 |
|
|
2021
Q1 | $601K | Buy |
5,558
+220
| +4% | +$23.5K | 0.33% | 85 |
|
|
2020
Q4 | $572K | Sell |
5,338
-300
| -5% | -$28.8K | 0.35% | 81 |
|
|
2020
Q3 | $494K | Sell |
5,638
-488
| -8% | -$45.9K | 0.37% | 85 |
|
|
2020
Q2 | $601K | Sell |
6,126
-1,600
| -21% | -$141K | 0.45% | 68 |
|
|
2020
Q1 | $589K | Hold |
7,726
| – | – | 0.48% | 61 |
|
|
2019
Q4 | $684K | Hold |
7,726
| – | – | 0.33% | 91 |
|
|
2019
Q3 | $585K | Hold |
7,726
| – | – | 0.25% | 116 |
|
|
2019
Q2 | $562K | Sell |
7,726
-25
| -0.3% | -$1.97K | 0.22% | 129 |
|
|
2019
Q1 | $625K | Sell |
7,751
-50
| -0.6% | -$4.09K | 0.23% | 125 |
|
|
2018
Q4 | $719K | Sell |
7,801
-175
| -2% | -$15.4K | 0.27% | 101 |
|
|
2018
Q3 | $754K | Hold |
7,976
| – | – | 0.23% | 124 |
|
|
2018
Q2 | $739K | Hold |
7,976
| – | – | 0.21% | 125 |
|
|
2018
Q1 | $831K | Hold |
7,976
| – | – | 0.24% | 116 |
|
|
2017
Q4 | $771K | Sell |
7,976
-100
| -1% | -$9.43K | 0.21% | 134 |
|
|
2017
Q3 | $718K | Sell |
8,076
-25
| -0.3% | -$1.9K | 0.19% | 141 |
|
|
2017
Q2 | $587K | Sell |
8,101
-150
| -2% | -$10.1K | 0.15% | 155 |
|
|
2017
Q1 | $538K | Sell |
8,251
-3
| -0% | -$189 | 0.14% | 160 |
|
|
2016
Q4 | $517K | Sell |
8,254
-175
| -2% | -$10.7K | 0.13% | 156 |
|
|
2016
Q3 | $532K | Sell |
8,429
-115
| -1% | -$7.45K | 0.13% | 155 |
|
|
2016
Q2 | $529K | Hold |
8,544
| – | – | 0.14% | 148 |
|
|
2016
Q1 | $488K | Buy |
8,544
+176
| +2% | +$9.81K | 0.12% | 160 |
|
|
2015
Q4 | $496K | Sell |
8,368
-50
| -0.6% | -$2.88K | 0.11% | 167 |
|
|
2015
Q3 | $458K | Sell |
8,418
-25
| -0.3% | -$1.63K | 0.1% | 180 |
|
|
2015
Q2 | $567K | Sell |
8,443
-100
| -1% | -$6.53K | 0.1% | 177 |
|
|
2015
Q1 | $500K | Sell |
8,543
-57
| -0.7% | -$3.44K | 0.09% | 198 |
|
|
2014
Q4 | $563K | Sell |
8,600
-10
| -0.1% | -$630 | 0.1% | 174 |
|
|
2014
Q3 | $497K | Hold |
8,610
| – | – | 0.09% | 203 |
|
|
2014
Q2 | $486K | Sell |
8,610
-900
| -9% | -$47.2K | 0.08% | 228 |
|
|
2014
Q1 | $489K | Sell |
9,510
-40
| -0.4% | -$2.02K | 0.08% | 238 |
|
|
2013
Q4 | $504K | Sell |
9,550
-25
| -0.3% | -$1.23K | 0.08% | 214 |
|
|
2013
Q3 | $428K | Hold |
9,575
| – | – | 0.08% | 200 |
|
|
2013
Q2 | $396K | Buy |
+9,575
| New | +$419K | 0.09% | 188 |
|
Other funds holding ABBV
Perritt Capital Management's ABBV Position: Q4 2025 in Review
Perritt Capital Management sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 4,342 shares — an estimated $1.01M sold.
Perritt Capital Management first reported a position in ABBV in Q2 2013 and held it in 50 quarters. The position peaked at $1.16M in Q1 2022. 4,148 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.
- Perritt Capital Management reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
- Perritt Capital Management sold 4,342 AbbVie shares in Q4 2025, an estimated $1.01M.
- Perritt Capital Management first reported a position in AbbVie in Q2 2013 and held it in 50 quarters.
- Perritt Capital Management's AbbVie position peaked at $1.16M in Q1 2022.
- 4,148 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.
Based on Perritt Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.